131 related articles for article (PubMed ID: 14636275)
1. Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathological parameters.
Xue WC; Khoo US; Ngan HY; Chan KY; Chiu PM; Tsao SW; Cheung AN
Histopathology; 2003 Nov; 43(5):485-90. PubMed ID: 14636275
[TBL] [Abstract][Full Text] [Related]
2. p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression.
Cheung AN; Shen DH; Khoo US; Wong LC; Ngan HY
J Clin Pathol; 1998 Feb; 51(2):159-62. PubMed ID: 9602692
[TBL] [Abstract][Full Text] [Related]
3. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
4. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions.
Xue WC; Khoo US; Ngan HY; Chan KY; Ip PP; Tsao SW; Cheung AN
Int J Gynecol Pathol; 2004 Apr; 23(2):145-50. PubMed ID: 15084843
[TBL] [Abstract][Full Text] [Related]
5. p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.
Siu MK; Yeung MC; Zhang H; Kong DS; Ho JW; Ngan HY; Chan DC; Cheung AN
Am J Pathol; 2010 Jun; 176(6):3015-22. PubMed ID: 20413688
[TBL] [Abstract][Full Text] [Related]
6. p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases.
Shoni M; Nagymanyoki Z; Vitonis AF; Jimenez C; Ng SW; Quade BJ; Berkowitz RS
Gynecol Oncol; 2013 Dec; 131(3):759-63. PubMed ID: 24051221
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
[TBL] [Abstract][Full Text] [Related]
8. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen.
Cheung AN; Ngan HY; Collins RJ; Wong YL
J Clin Pathol; 1994 Jul; 47(7):601-4. PubMed ID: 8089214
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of the proliferative marker Ki67 in hydatidiform moles and its diagnostic value in the progression to gestational trophoblastic neoplasia.
Hasanzadeh M; Sharifi N; Esmaieli H; Daloee MS; Tabari A
J Obstet Gynaecol Res; 2013 Feb; 39(2):572-7. PubMed ID: 22925155
[TBL] [Abstract][Full Text] [Related]
10. Id helix-loop-helix proteins are differentially expressed in gestational trophoblastic disease.
Xue WC; Feng HC; Chan KY; Chiu PM; Ngan HY; Khoo US; Tsao SW; Chan KW; Cheung AN
Histopathology; 2005 Sep; 47(3):303-9. PubMed ID: 16115231
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) expression in gestational trophoblastic diseases (GTD).
Molykutty J; Rajalekshmy TN; Balaraman NM; Swapna E; Krishnan NM; Balaram P
Neoplasma; 1998; 45(5):301-4. PubMed ID: 9921919
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen in human placenta and trophoblastic disease.
Wolf HK; Michalopoulos GK
Pediatr Pathol; 1992; 12(2):147-54. PubMed ID: 1349168
[TBL] [Abstract][Full Text] [Related]
13. Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases.
Uzunlar AK; Yilmaz F; Bayhan G; Akkuş Z
Eur J Gynaecol Oncol; 2002; 23(1):79-83. PubMed ID: 11876401
[TBL] [Abstract][Full Text] [Related]
14. Use of proliferation cell nuclear antigen immunoreactivity for distinguishing hydropic abortions from partial hydatidiform moles.
Suresh UR; Hale RJ; Fox H; Buckley CH
J Clin Pathol; 1993 Jan; 46(1):48-50. PubMed ID: 8094402
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and mutational analysis of p53 tumor suppressor gene in gestational trophoblastic disease: correlation with mdm2, proliferation index, and clinicopathologic parameters.
Cheung AN; Shen DH; Khoo US; Chiu MP; Tin VP; Chung LP; Ngan HY
Int J Gynecol Cancer; 1999 Mar; 9(2):123-130. PubMed ID: 11240753
[TBL] [Abstract][Full Text] [Related]
16. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
17. The significance of proliferating cell nuclear antigen in human trophoblastic disease: an immunohistochemical study.
Cheung AN; Ngan HY; Chen WZ; Loke SL; Collins RJ
Histopathology; 1993 Jun; 22(6):565-8. PubMed ID: 8102616
[TBL] [Abstract][Full Text] [Related]
18. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
[TBL] [Abstract][Full Text] [Related]
19. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
20. GATA3 expression in gestational trophoblastic tissues and tumours.
Mirkovic J; Elias K; Drapkin R; Barletta JA; Quade B; Hirsch MS
Histopathology; 2015 Nov; 67(5):636-44. PubMed ID: 25753145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
